Phase IThyroid Analog
Compound 61716
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061716
Risk Class
MODERATE
Last Audit
Jun 27, 2108
Research Abstract
Thyroid Analog candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 61716 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in phase i with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061716 with updates logged 2108-06-27.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-61716Thyroid Analog Program 61716
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061716
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61716